Assess the data and tweets to estimate whether the closing price of $amgn will escalate or deflate at 2014-01-22. Respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2014-01-07,-2.5,0.3,-2.7,2.6,2.6,-1.4,-1.7,-2.2,-2.4,-2.4,-2.4
2014-01-08,0.7,0.9,-0.5,-0.5,-0.5,-0.6,-1.0,-1.6,-1.8,-1.9,-1.8
2014-01-09,-2.0,0.1,-2.2,2.6,2.6,-2.6,-2.9,-3.6,-4.1,-4.2,-4.2
2014-01-10,0.9,0.9,-1.5,-0.8,-0.8,-1.2,-1.9,-2.6,-3.2,-3.3,-3.3
2014-01-13,1.6,2.0,-0.4,-1.3,-1.3,0.6,-0.4,-1.0,-1.7,-1.8,-1.9
2014-01-14,-0.7,0.2,-1.3,1.1,1.1,-0.3,-1.4,-1.9,-2.6,-2.8,-2.9
2014-01-15,-0.1,0.4,-0.9,0.7,0.7,-0.5,-1.6,-2.3,-2.9,-3.3,-3.5
2014-01-16,-0.2,0.6,-0.7,0.4,0.4,-0.9,-1.8,-2.3,-3.0,-3.6,-3.7
2014-01-17,-0.2,0.3,-0.7,0.1,0.1,-0.8,-1.5,-2.2,-2.9,-3.5,-3.6
2014-01-21,0.6,0.6,-0.6,0.1,0.1,-0.4,-1.1,-2.0,-2.7,-3.3,-3.6

2014-01-08: rt AT_USER ubs key events: $celg $gild $biib $amgn $regn |$xncr is eligible for up to $1.3b milestone paymts from partnerships w $mor $amgn $alxn $jnj $csl.ax $mrk bi[wedbush] |s&amp;p100 #stocks tren
2014-01-09: $amgn - amgen vs. merck, lilly in osteoporosis competition -&gt;  #stock #stocks #stockaction
2014-01-15: rt AT_USER few companies generate cash flow as effectively and consistently as amgen  $amgn
Answer:
Rise